Ascend Wellness Holdings (AAWH) Revenue (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Revenue came in at $116.9 million in Q1 2026, down 8.64% year-on-year from $128.0 million in Q1 2025, and down 3.0% quarter-over-quarter from $120.5 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Revenue (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Revenue history runs 7 years deep, the most recent figure standing at $116.9 million for Q1 2026.
- On a quarterly basis, Revenue fell 8.64% year-over-year to $116.9 million in Q1 2026; TTM through Mar 2026 was $489.5 million, a 10.54% decrease from a year earlier, with the FY2025 full-year figure at $500.6 million, down 10.87% from the prior year.
- Revenue fell to $116.9 million in Q1 2026 per AAWH's latest filing, from $120.5 million in the prior quarter.
- Across five years, Revenue topped out at $142.4 million in Q1 2024 and bottomed at $85.1 million in Q1 2022.
- The 5-year median for Revenue is $124.7 million (2025), against an average of $123.7 million.
- Across the five-year window, Revenue jumped 34.18% in 2023 and decreased 11.94% in 2025, its largest moves.
- Year by year, Revenue stood at $112.1 million in 2022, then increased by 25.03% to $140.2 million in 2023, then slipped by 2.96% to $136.0 million in 2024, then declined by 11.37% to $120.5 million in 2025, then fell by 3.0% to $116.9 million in 2026.
- Per Business Quant, the three latest AAWH Revenue figures stand at $116.9 million (Q1 2026), $120.5 million (Q4 2025), and $124.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Ascend Wellness Holdings | 80.98 Mn | 20.06 Mn | 44.88 Mn | 116.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.93 Mn |
| Dec 31, 2025 | 120.55 Mn |
| Sep 30, 2025 | 124.73 Mn |
| Jun 30, 2025 | 127.30 Mn |
| Mar 31, 2025 | 128.00 Mn |
| Dec 31, 2024 | 136.01 Mn |
| Sep 30, 2024 | 141.65 Mn |
| Jun 30, 2024 | 141.54 Mn |
| Mar 31, 2024 | 142.41 Mn |
| Dec 31, 2023 | 140.16 Mn |
| Sep 30, 2023 | 141.27 Mn |
| Jun 30, 2023 | 122.99 Mn |
| Mar 31, 2023 | 114.18 Mn |
| Dec 31, 2022 | 112.10 Mn |
| Sep 30, 2022 | 111.24 Mn |
| Jun 30, 2022 | 97.50 Mn |
| Mar 31, 2022 | 85.09 Mn |
| Dec 31, 2021 | 88.50 Mn |
| Sep 30, 2021 | 94.38 Mn |
| Jun 30, 2021 | 83.37 Mn |